Wixela vs Breo

Wixela vs Breo

What to choose Wixela or Breo

Wixela is inhaler of type Control while Breo is of Rescue type. Wixela and Breo are both brand inhalers. Wixela is manufactured by pharmaceutical company Viatris, while Breo is manufactured by GSK. The main substances of Wixela are Fluticasone and Salmeterol. The available dosage for Wixela is 250/50. The main substance of Breo is Vilanterol. The available dosages for Breo are 100/25, 200/25.

The average price for Wixela is around $240 per inhaler while actual cost for Breo is roughly $145 per inhaler, said Jonathan Butler, a Scholar at the State University of New York College of Environmental Science and Forestry and a Physician at a clinic that uses Wixela and Breo.

Wixela and Breo Comparison

Wixela vs Breo
Wixela Breo
Type: Control Rescue
Manufacturer: Viatris GSK
Substance: Fluticasone + Salmeterol Vilanterol
Dosage: 250/50 100/25, 200/25
Avg Price: $240 $145